Learn how one CDMO is at the forefront of green chemistry, applying its principles to reduce the environmental and human impact of pharmaceutical production.
Selection of the proper technology can make the difference between development success or failure. Learn more in this whitepaper from Lonza Pharma & Biotech.
Market research estimates performed in the last 6 months have shown that the market size for
ophthalmic medications is expected to reach more than 25 billion, by the year 2015. The ophthalmology
drugs market classification is based on the type of drugs: treatment-based drugs, over-the-counter (OTC)
drugs and ocular anesthetics.